Cowen and Company’s G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 GSQB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-135,473
Closed -$5.42K 685
2023
Q1
$5.42K Sell
135,473
-3,951
-3% -$182 ﹤0.01% 458
2022
Q4
$5.59K Buy
139,424
+37,724
+37% +$2.48K ﹤0.01% 468
2022
Q3
$10K Hold
101,700
﹤0.01% 432
2022
Q2
$13K Buy
+101,700
New +$26.7K ﹤0.01% 454

Other funds holding GSQB.WS

Cowen and Company's GSQB.WS Position: Q2 2023 in Review

Cowen and Company sold out of G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (GSQB.WS) in Q2 2023, closing a stake of 135,473 shares — an estimated $5.42K sold.

Cowen and Company first reported a position in GSQB.WS in Q2 2022 and held it in 4 quarters. The position peaked at $13K in Q2 2022. 3 funds tracked by Wall St. Rank hold GSQB.WS as of Q2 2023.

  • Cowen and Company reported no remaining G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Cowen and Company sold 135,473 G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $5.42K.
  • Cowen and Company first reported a position in G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2022 and held it in 4 quarters.
  • Cowen and Company's G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $13K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.